Infectious complications after cardiac transplantation in man.
D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D005260:Female; D016027:Heart Transplantation; D006801:Humans; D007239:Infections / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000188:drug therapy / Q000209:etiology*; D009761:Nystatin / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011409:Propylene Glycols / Q000627:therapeutic use; D011528:Protozoan Infections / Q000188:drug therapy / Q000209:etiology*; D012141:Respiratory Tract Infections / Q000175:diagnosis / Q000188:drug therapy; D018805:Sepsis / Q000175:diagnosis / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000175:diagnosis / Q000188:drug therapy; D014181:Transplantation Immunology; D014184:Transplantation, Homologous; D014552:Urinary Tract Infections / Q000175:diagnosis / Q000188:drug therapy; D014777:Virus Diseases / Q000188:drug therapy / Q000209:etiology*
D000961:Antilymphocyte Serum; D011409:Propylene Glycols; D009761:Nystatin; D003609:Dactinomycin; D000666:Amphotericin B; D001379:Azathioprine; D011241:Prednisone